Ainos, a healthcare company, has made significant progress in the clinical trials of its AI-powered point-of-care testing device, Ainos Flora. The trials have demonstrated improved accuracy and reliability of the device, paving the way for its next-generation development. Ainos Flora aims to provide rapid and non-invasive detection of infections in women.
